Blog Archives

PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for

Tagged with: , , , , , , , , , , , , , , , , , ,

Objective Motion Sensor Assessment Highly Correlated with Scores of Global Levodopa-Induced Dyskinesia in Parkinson’s Disease

T. Mera, M. Burack, J. Giuffrida J Parkinsons Dis. 2013 Jan 1;3(3):399-407.

Tagged with: , , , , , ,

Tradeshow Event: Partnership in Clinical Trials

The Mirage Hotel Las Vegas, NV March 31 – April 2 2014 Conference home page We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems. From the 2013 event: This year’s event

Tagged with: , , , , , , , , , , ,

PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities

VIEW PRESS RELEASE [PDF] 03 DEC 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor

Tagged with: , , , , , , , , , , , ,

PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]  05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The

Tagged with: , , , , , , , , , , , , , , ,

Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology

T. Mera, M. Burack, J. Giuffrida Conf Proc IEEE Eng Med Biol Soc. 2012.

Tagged with: , , , ,

PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] March 23, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with

Tagged with: , , , , , , , , , , , , , , , , , ,

PRESS RELEASE: GLNT Awarded Patent for Technology to Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 8MAR2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have received allowance of claims from the U.S. Patent Office for an application covering their Movement Disorder Monitoring System and Method for quantitative assessment

Tagged with: , , , , , , , , , , , , , , , , , , , ,

Automated Parkinson’s Disease Gait and Balance Assessment for Optimization of Deep Brain Stimulation

T. Mera, D. Filipkowski, Riley R, Walter B, Gunzler S, J. Giuffrida International Congress of Parkinson’s Disease and Movement Disorders, Toronto, CA 2011

Tagged with: , , , , , , ,

Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor

M. Giovanni, J. Giuffrida, O. Adam, A. Davidson, J. Jankovic Mov Disord. 2010 Sep 15;25(12):1938-43

Tagged with: , , , ,